Members of the AstraZeneca project team found themselves challenged by the need to find a solution that balanced business needs, regulatory criteria, and the sophisticated requirements of their graphic arts users.
"We needed a company that could address the graphic arts needs for packaging within the pharmaceutical industry," said Steve Burgess, AstraZeneca project lead.
"In the final analysis two key factors of equal importance emerged when making a decision--the graphics handling capabilities of the software solution and the domain expertise of the people developing and supporting the product," added Burgess.
Kathy Pazely, vice president of operations at InterchangeDigital stated, "Consistent with our strategic plan, we have enhanced our PaRTS offering to facilitate consumer products companies' ability to meet their demands for enhanced speed and efficiency. We have done so with the commitment to ensure that PaRTS will also comply with regulatory requirements as they may change from time to time. We are delighted that AstraZeneca has shown confidence in PaRTS and look forward to observing the improved efficiencies that the PaRTS solution will deliver."
Paul Goldberg, technical director of Gap Systems commented, "PaRTS will be deployed to over one thousand users across the AstraZeneca enterprise and will reduce packaging time to market, maintain regulatory compliance and improve collaboration and artwork approvals."
Andrew Garnham, vice president of marketing for Gap Systems noted, "Gap Systems has been a key partner with InterchangeDigital for several years, helping them serve companies that require a seamless global service at the local level."
InterchangeDigital's PaRTS software offers a best of breed solution for organizations that need to store, manage and repurpose graphic elements within a regulated and managed environment. When process workflows, graphic assets and Online Proofing (OLP) are implemented, a PaRTS solution provides an invaluable tool for global organizations requiring greater control over their labeling and packaging processes.
PaRTS(R) (Production and Resource Tracking System), also complies fully with FDA Title 21 Code Federal Regulations Part 11: Electronic Records and Electronic Signatures (US FDA 21 CFR Part 11). For a copy of the white paper outlining this compliance, visit www.interchangedigital.com.
Gap Systems Europe Limited, with offices in the U.K., supplies global solutions that address the graphics product life cycle component (GPL) of the packaging supply chain. Gap Systems Europe Limited supplies solutions to major retailers, consumer goods companies, brand houses and pharmaceutical companies. Gap Systems enables its clients to achieve faster time to market by increasing collaboration between stakeholders delivered through web-based software solutions and dedicated applications. For more information on Gap Systems, contact: firstname.lastname@example.org at www.gapsystems.net
InterchangeDigital, an innovator in the development, deployment and management of software for integrated digital asset management solutions has been serving the needs of the consumer packaged goods clients since 1997. InterchangeDigital's software product, PaRTS(R), allows global organizations to integrate their packaging development workflow online, creating a collaborative environment that streamlines their business process, reduces overall workflow costs, ensures global brand consistency, permits re-purposing of digital assets, and helps speed new products to market. PaRTS has also been adapted to meet the highly specialized needs of pharmaceutical manufacturers. For more information on InterchangeDigital, visit www.interchangedigital.com. InterchangeDigital is a wholly owned subsidiary of Schawk, Inc. Focused on the packaging market since its inception in 1953, today Schawk employs more than 1,400 people around the world and counts many of the world's largest multinational consumer packaged goods and pharmaceutical manufacturers as its clients. Schawk trades on the NYSE under symbol "SGK." For more information on Schawk, visit www.schawk.com.
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index. For more information on AstraZeneca, please contact: Joan Pitt Director of Communications, Global Operations (email@example.com) +44 1625 519079 or please visit www.astrazenecapressoffice.com.
Schawk, Inc. Kathy Melvage, 847-827-9494 Email Contact or InterchangeDigital, Inc. Kathy Pazely, 847-370-9814 Email Contact or Gap Systems Europe Andrew Garnham, +44 020 7566 1435